Advertisement
Research Article| Volume 50, ISSUE 4, P797-804, April 2009

Download started.

Ok

Influence of ethnicity on histological differences in non-alcoholic fatty liver disease

Published:January 05, 2009DOI:https://doi.org/10.1016/j.jhep.2008.11.017

      Background/Aims

      Previous studies examining ethnic differences in non-alcoholic fatty liver disease (NAFLD) are limited by small sample sizes and the lack of liver biopsy as a diagnostic modality.

      Methods

      We retrospectively examined the influence of ethnicity on the biochemical and liver histological differences in NAFLD patients.

      Results

      The proportion of African Americans (AA) in the NAFLD sample (total 238 patients; 15.1% AA) was lower than in the base population (68.2%). Median ALT (47 IU/L; p = 0.05) and triglyceride (134 mg/dL, p = 0.002) levels were lower in AA than other ethnicities. AA showed lower degrees of steatosis [odds ratio (OR) 0.44, 95% confidence interval (CI) 0.22–0.89; p = 0.02] than Whites. In contrast, Asians showed higher grades of ballooning than Whites (OR 2.67, 95% CI 1.03–6.93; p = 0.04) and other ethnicities combined (OR 2.71, 95% CI 1.06–6.92; p = 0.04). Hispanics showed a higher rate of Mallory bodies than Whites (OR 2.38, 95% CI 1.05–5.39; p = 0.04) and other ethnicities combined (OR 2.41, 95% CI 1.09–5.34; p = 0.03).

      Conclusions

      African Americans showed a lower degree of steatosis than Whites. In contrast, Asians and Hispanics showed higher grades of ballooning and Mallory bodies, respectively, than Whites and other ethnicities combined. These findings highlight the need for prospective studies to evaluate ethnic differences in NAFLD.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Browning J.D.
        • Szczepaniak L.S.
        • Dobbins R.
        • Nuremberg P.
        • Horton J.D.
        • Cohen J.C.
        • et al.
        Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.
        Hepatology. 2004; 40: 1387-1395
        • Browning J.D.
        • Kumar K.S.
        • Saboorian M.H.
        • Thiele D.L.
        Ethnic differences in the prevalence of cryptogenic cirrhosis.
        Am J Gastroenterol. 2004; 99: 292-298
        • Caldwell S.H.
        • Harris D.M.
        • Patrie J.T.
        • Hespenheide E.E.
        Is NASH underdiagnosed among African Americans?.
        Am J Gastroenterol. 2002; 97: 1496-1500
        • Kemmer N.M.
        • McKinney K.H.
        • Xiao S.-Y.
        • Singh H.
        • Murray R.
        High prevalence of NASH among Mexican American females with type II diabetes mellitus.
        Gastroenterology. 2001; 120: A117
        • Louthan M.V.
        • Theriot J.A.
        • Zimmerman E.
        • Stutts J.T.
        • McClain C.J.
        Decreased prevalence of nonalcoholic fatty liver disease in black obese children.
        J Pediatr Gastroenterol Nutr. 2005; 41: 426-429
        • Santos L.
        • Molina E.G.
        • Jeffers L.
        Prevalence of nonalcoholic steatohepatitis among ethnic groups.
        Gastroenterology. 2001; 120: A117
        • Schwimmer J.B.
        • McGreal N.
        • Deutsch R.
        • Finegold M.J.
        • Lavine J.E.
        Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.
        Pediatrics. 2005; 115: e561-e565
        • Weston S.R.
        • Leyden W.
        • Murphy R.
        • Bass N.M.
        • Bell B.P.
        • Manos M.M.
        • et al.
        Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease.
        Hepatology. 2005; 41: 372-379
        • Angulo P.
        Nonalcoholic fatty liver disease.
        N Engl J Med. 2002; 346: 1221-1231
        • Clark J.M.
        • Brancati F.L.
        • Diehl A.M.
        Nonalcoholic fatty liver disease.
        Gastroenterology. 2002; 122: 1649-1657
        • Neuschwander-Tetri B.A.
        • Caldwell S.H.
        Nonalcoholic steatohepatitis: summary of an AASLD single topic conference.
        Hepatology. 2003; 37: 1202-1219
        • Younossi Z.M.
        • Diehl A.M.
        • Ong J.P.
        Nonalcoholic fatty liver disease: an agenda for clinical research.
        Hepatology. 2002; 35: 746-752
        • Bedogni G.
        • Bellentani S.
        Fatty liver: how frequent is it and why?.
        Ann Hepatol. 2004; 3: 63-65
        • Day C.P.
        Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?.
        Gut. 2002; 50: 585-588
        • Kumar S.K.
        • Malet P.F.
        Nonalcoholic steatohepatitis.
        Mayo Clinic Proc. 2000; 75: 733-739
        • Marchesini G.
        • Bugianesi E.
        • Forlani G.
        • Cerrelli F.
        • Lenzi M.
        • Manini R.
        • et al.
        Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
        Hepatology. 2003; 37: 917-923
        • Sheth S.G.
        • Gordon F.D.
        • Chopra S.
        Nonalcoholic steatohepatitis.
        Ann Intern Med. 1997; 126: 137-145
        • Wanless I.R.
        • Lentz J.S.
        Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
        Hepatology. 1990; 12: 1106-1110
        • American Diabetes Association
        Standards of medical care in diabetes.
        Diabetes Care. 2004; 27: S15-S35
      1. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497.

      2. World Health Organization. Report of a WHO consultation: definition of metabolic syndrome in definition, diagnosis and classification of diabetes mellitus and its complications. Department of Noncommunicable Disease Surveilance, Geneva: World Health Organization; 1999.

        • Kleiner D.E.
        • Brunt E.M.
        • Van Natta M.
        • Behling C.
        • Contos M.J.
        • Cummings O.W.
        • et al.
        Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
        Hepatology. 2005; 41: 1313-1321
        • Solga S.F.
        • Clark J.M.
        • Alkhuraishi A.R.
        • Torbenson M.
        • Tabesh A.
        • Schweitzer M.
        • et al.
        Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients.
        Surg Obes Relat Dis. 2005; 1: 6-11
        • UK Prospective Diabetes Study (UKPDS)
        XI: biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects.
        Diabet Med. 1994; 11: 534-544
        • Abate N.
        • Garg A.
        • Peshock R.M.
        • Stray-Gundersen J.
        • Adams-Huet B.
        • Grundy S.M.
        Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM.
        Diabetes. 1996; 45: 1684-1693
        • Banerji M.A.
        • Lebovitz H.E.
        Insulin action in black Americans with NIDDM.
        Diabetes Care. 1992; 15: 1295-1302
        • Banerji M.A.
        • Norin A.J.
        • Chaiken R.L.
        • Lebovitz H.E.
        HLA-DQ associations distinguish insulin-resistant and insulin-sensitive variants of NIDDM in black Americans.
        Diabetes Care. 1993; 16: 429-433
        • Marchesini G.
        • Brizi M.
        • Morselli-Labate A.M.
        • Bianchi G.
        • Bugianesi E.
        • McCullough A.J.
        • et al.
        Association of nonalcoholic fatty liver disease with insulin resistance.
        Am J Med. 1999; 107: 450-455
        • Ford E.S.
        • Giles W.H.
        • Dietz W.H.
        Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey.
        JAMA. 2002; 287: 356-359
        • McCullough A.J.
        Update on nonalcoholic fatty liver disease.
        J Clin Gastroenterol. 2002; 34: 255-262
        • Bari M.R.
        • Ostgren C.J.
        • Rastam L.
        • Lindblad U.
        Abdominal obesity and insulin resistance in patients with type 2 diabetes in a Swedish community. Skaraborg hypertension and diabetes project.
        Scand J Prim Health Care. 2006; 24: 211-217
        • Omagari K.
        • Kadokawa Y.
        • Masuda J.
        • Egawa I.
        • Sawa T.
        • Hazama H.
        • et al.
        Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics.
        J Gastroenterol Hepatol. 2002; 17: 1098-1105
        • Cheung O.
        • Kapoor A.
        • Puri P.
        • Sistrun S.
        • Luketic V.A.
        • Sargeant C.C.
        • et al.
        The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome.
        Hepatology. 2007; 46: 1091-1100
        • Shen L.
        • Fan J.G.
        • Shao Y.
        • Zeng M.D.
        • Wang J.R.
        • Luo G.H.
        • et al.
        Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey.
        World J Gastroenterol. 2003; 9: 1106-1110
        • Petersen K.F.
        • Dufour S.
        • Feng J.
        • Befroy D.
        • Dziura J.
        • Dalla Man C.
        • et al.
        Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.
        Proc Natl Acad Sci USA. 2006; 103: 18273-18277
        • Deurenberg P.
        • Deurenberg-Yap M.
        • Guricci S.
        Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship.
        Obes Rev. 2002; 3: 141-146
        • Galassi A.
        • Reynolds K.
        • He J.
        Metabolic syndrome and risk of cardiovascular disease: a meta-analysis.
        Am J Med. 2006; 119: 812-819
        • Gupta M.
        • Singh N.
        • Verma S.
        South Asians and cardiovascular risk: what clinicians should know.
        Circulation. 2006; 113: e924-e929
        • Hsieh S.D.
        • Yoshinaga H.
        • Muto T.
        • Sakurai Y.
        • Kosaka K.
        Health risks among Japanese men with moderate body mass index.
        Int J Obes Relat Metab Disord. 2000; 24: 358-362
        • Palep-Singh M.
        • Picton H.M.
        • Barth J.H.
        • Balen A.H.
        Ethnic variations in the distribution of obesity and biochemical metabolic abnormalities in fertility clinic attendees.
        J Reprod Med. 2008; 53: 117-123
        • Araneta M.R.
        • Barrett-Connor E.
        Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and White women.
        Obes Res. 2005; 13: 1458-1465
        • Ajjan R.
        • Carter A.M.
        • Somani R.
        • Kain K.
        • Grant P.J.
        Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome.
        J Thromb Haemost. 2007; 5: 754-760
        • Collantes R.
        • Ong J.P.
        • Younossi Z.M.
        Nonalcoholic fatty liver disease and the epidemic of obesity.
        Cleve Clin J Med. 2004; 71: 657-664
        • Karpe F.
        • Lundahl B.
        • Ehrenborg E.
        • Eriksson P.
        • Hamsten A.
        A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels.
        Arterioscler Thromb Vasc Biol. 1998; 18: 756-761
        • Namikawa C.
        • Shu-Ping Z.
        • Vyselaar J.R.
        • Nozaki Y.
        • Nemoto Y.
        • Ono M.
        • et al.
        Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis.
        J Hepatol. 2004; 40: 781-786
        • Ruhl C.E.
        • Everhart J.E.
        Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.
        Gastroenterology. 2003; 124: 71-79
        • Celona A.F.
        • Yu M.C.
        • Prakash M.
        • Kuo T.
        • Bonacini M.
        Hepatitis C in a Los Angeles public hepatitis clinic: demographic and biochemical differences associated with race-ethnicity.
        Clin Gastroenterol Hepatol. 2004; 2: 459-462
        • Sterling R.K.
        • Stravitz R.T.
        • Luketic V.A.
        • Sanyal A.J.
        • Contos M.J.
        • Mills A.S.
        • et al.
        A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans.
        Clin Gastroenterol Hepatol. 2004; 2: 469-473
        • Misra A.
        • Vikram N.K.
        Insulin resistance syndrome (metabolic syndrome) and Asian Indians.
        Curr Sci. 2002; 83: 1483-1496
        • Mohan V.
        • Deepa M.
        • Deepa R.
        • Shanthirani C.S.
        • Farooq S.
        • Ganesan A.
        • et al.
        Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India – the Chennai urban rural epidemiology study (CURES-17).
        Diabetologia. 2006; 49: 1175-1178